Anxiety is Linked to Gut Health

Could probiotics help treat it?

Translate to Spanish or other 102 languages!

Anxiety is linked to decreased diversity in gut bacteria. Could probiotics help treat it? Image for illustration purposes
Anxiety is linked to decreased diversity in gut bacteria. Could probiotics help treat it? Image for illustration purposes
- Advertisement -
  • Experts are interested in how the gut microbiota may influence mental health conditions like anxiety.
  • One narrative review suggests that people with anxiety can experience decreased microbial diversity and fewer short-chain fatty acid-producing bacteria.
  • The finding also suggests that using probiotics could help to improve anxiety symptoms.

The gut microbiota refers to the microorganisms that live in the gut.

A narrative review recently published in the journal Nutrients sought to look at data on changes in the gut microbiota in people with anxiety disorders and on how probiotics may help improve anxiety symptoms.

Follow the link below to read the full story on Medical News Today:

- Advertisement -

https://www.medicalnewstoday.com/articles/anxiety-is-linked-to-gut-health-could-probiotics-help-treat-it?slot_pos=article_1&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2025-03-18&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Texas Adds New Condition to Mandatory Newborn Screening Tests

The Texas Department of State Health Services added a new enzyme deficiency test on June 1, 2026, to its newborn screening panel, meaning that all Texas newborns are now tested for 60 rare, genetic conditions. Tests for hearing loss and critical congenital heart disease are additional point-of-service tests typically conducted by the birthing center. 

Pancreatic Cancer Patients Gain Early Access to Experimental Drug Daraxonrasib Following Fast-Track FDA Decision

The U.S. Food and Drug Administration is announcing that it issued a “safe to proceed” letter to Revolution Medicines, allowing the sponsor to initiate an expanded access treatment protocol (EAP) for its experimental pancreatic cancer drug, daraxonrasib.

STHS GME Consortium Encourages Community to “Walk with a Doc”, June 6th

Mega Doctor News In an era defined by high-intensity workouts, wearable fitness trackers and advanced training techniques, one of simplest...

Study: Menopause Hormone Therapy Declines Nationwide Despite Proven Benefits

Hormone therapy use among women in the U.S. remains low, even though it's an effective treatment for many menopause symptoms, according to a new Mayo Clinic study published in Mayo Clinic Proceedings.
- Advertisement -